Montreal cognitive assessment as a screening instrument for cognitive impairment in systemic lupus erythematosus patients without overt neuropsychiatric manifestations.

Xin Rong LimPamela Oi Khuan ChewGek Hsiang LimYung Ling LowJune Wei Ping LimHuey Ni OngWeng Giap LawJustina Wei Lynn TanBernard Yu-Hor ThongFaith Li-Ann ChiaTsui Yee LianGrace Yin Lai ChanMadelynn Tsu-Li ChanEe Tzun KohKok Ooi KongHwee Siew Howe

Published in: Lupus (2022)

MoCA may be a useful screening tool to identify the most frequently affected cognitive domain which is executive functioning using a lower cutoff of <25 in SLE patients without overt neuropsychiatric manifestations.

Keyphrases

end stage renal disease
newly diagnosed
cognitive impairment
prognostic factors
patient reported outcomes
rheumatoid arthritis
working memory